Finance

Lists
SUPN:NASDAQ
Supernus Pharmaceuticals Inc
43,05 USD
+0,51%
(+0,22) 1D
43,05 USD
0,00% (0,00)
After hours
Closed: 7-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SUPN...
Open
42,24 USD
High
43,38 USD
Low
42,24 USD
Mkt. cap
2,51 млд
Avg. vol.
635,26 миң
Volume
0,00
52-wk high
59,68 USD
52-wk low
40,52 USD
EPS
-1,91 USD
Beta
0,55
Shares outstanding
58,22 млн
No. of employees
778
Open
42,24 USD
High
43,38 USD
Low
42,24 USD
Mkt. cap
2,51 млд
Avg. vol.
635,26 миң
Volume
0,00
52-wk high
59,68 USD
52-wk low
40,52 USD
EPS
-1,91 USD
Beta
0,55
Shares outstanding
58,22 млн
No. of employees
778
News stories
From web sources and news partners
About Supernus Pharmaceuticals Inc
CEOJack A. Khattar
Employees778
Founded2005
HeadquartersРоквилл, Мэриленд, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websitesupernus.com
Analyst ratings
Based on 5 analysts giving stock ratings to SUPN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for SUPN in the last 3 months.
Highest
Current 43,05 USD
67,00 USD (+55,63%)
Average
65,20 USD (+51,45%)
Lowest
63,00 USD (+46,34%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stacy Ku
TD Cowen
Buy
Maintained
65,00 USD
+51%
08/03/2026
David Amsellem
Piper Sandler
Buy
Reiterated
66,00 USD
+53,3%
07/27/2026
Jason Gerberry
Bank of America Securities
Buy
Maintained
63,00 USD
+46,3%
07/13/2026
Chi Meng Fong
Bank of America Securities
Buy
Maintained
63,00 USD
+46,3%
07/13/2026
Unknown Analyst
Jefferies
Buy
Maintained
65,00 USD
+51%
07/10/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
67,00 USD
+55,6%
07/09/2026
Annabel Samimy
Stifel Nicolaus
Hold
Maintained
55,00 USD
+27,8%
05/06/2026
Pavan Patel
Bank of America Securities
Buy
Maintained
65,00 USD
+51%
02/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
192,10 млн
211,57 млн
207,70 млн
219,06 млн
Cost of goods sold
48,33 млн
50,83 млн
62,83 млн
63,13 млн
Cost of revenue
48,33 млн
50,83 млн
62,83 млн
63,13 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110,97 млн
124,44 млн
126,67 млн
136,04 млн
Operating expense
135,30 млн
148,96 млн
152,32 млн
161,37 млн
Total operating expenses
183,63 млн
199,80 млн
215,15 млн
224,50 млн
Operating income
8,48 млн
11,77 млн
-7,44 млн
-5,44 млн
Other non operating income
-
-
-
-
EBT including unusual items
-57,95 млн
-1,91 млн
-5,95 млн
-57,65 млн
EBT excluding unusual items
10,75 млн
14,24 млн
-5,06 млн
-5,13 млн
Income tax expense
-12,84 млн
2,19 млн
-3,66 млн
723,00 миң
Effective tax rate
22,15%
-114,47%
61,46%
-1,25%
Other operating expenses
-
-
-
-
Net income
-45,12 млн
-4,10 млн
-2,29 млн
-58,37 млн
Net profit margin
-23,49%
-1,94%
-1,10%
-26,65%
Earnings per share
0,61
0,88
0,21
0,53
Interest and investment income
2,28 млн
2,46 млн
2,38 млн
2,63 млн
Interest expense
-
-
-
-2,32 млн
Net interest expenses
2,28 млн
2,46 млн
2,38 млн
315,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
33,28 млн
36,79 млн
18,69 млн
20,30 млн
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору